Physician profile
Sanjay Suwal
NPI 1710339163
$3,124.72
in general payments reported to CMS, 2019-2025
18 companies · $639 in 2025
The $639 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $162 · 2021: $148 · 2022: $552 · 2023: $671 · 2024: $641 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,950.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,143.81 | 2019-2025 | Lifevest |
| Pfizer INC. | $448.56 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $328.24 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $324.08 | 2021-2024 | |
| Abbvie INC. | $299.06 | 2021-2025 | Teflaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $84.96 | 2019-2023 | Farxiga |
| Cvrx, INC. | $81.19 | 2022-2024 | Barostim Neo System |
| Allergan, INC. | $43.78 | 2019-2020 | |
| Abbott Laboratories | $43.68 | 2024-2025 | Cardiomems |
| Janssen Scientific Affairs, LLC | $37.29 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $35.25 | 2024 | Assure Wcd |
| Insmed, INC. | $32.43 | 2019 | |
| Boston Scientific Corporation | $31.08 | 2022 | |
| Medtronic USA, INC. | $20.35 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.39 | 2023 | Starling System |
| Smith+Nephew, INC. | $15.96 | 2025 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Suwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.